The issuer is solely responsible for the content of this announcement.

U.K., Director in the Board of Glaxo India Ltd, Non-Executive Director ... tech equipment and capital goods. • Technology cooperation with global pharmaceutical companies not only stimulates ...

Ascentage Pharma has been listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock ... The company has built a rich pipeline of innovative drug candidates that includes ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

GSK's pill, the first oral antibiotic for urinary tract infections in almost 30 years, comes as bacteria are increasingly ...

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine targeting a chronic blood disorder.

In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against other stocks that Jim Cramer discussed 12 months ago. During the latest ...

China's pharmaceutical industry is witnessing a growing appetite for innovative drugs, as the government continues to implement policies and measures aimed at ensuring Chinese patients can benefit ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Bertalan Mesko highlights some of the key trends that are set to change our approach to health and wellbeing – and the way pharma does ... the human touch and innovative technologies will ...

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...